(S (NP (PRP It)) (VP (VBZ is) (VP (ADVP (RB widely)) (VBN accepted) (SBAR (IN that) (S (NP (DT the) (NN immune) (NN system)) (VP (JJ undergoes) (NP (NP (JJ age-related) (NNS changes)) (VP (VBG correlating) (PP (IN with) (NP (NP (JJ increased) (NN disease)) (PP (IN in) (NP (DT the) (JJ elderly)))))))))))) (. .))
(S (NP (NNP T) (NN cell) (NNS subsets)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated)))) (. .))
(S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBZ is) (ADVP (RB firstly)) (S (VP (TO to) (VP (VB implement) (CC and) (VB validate) (NP (NP (DT a) (NN simulation)) (PP (IN of) (NP (NP (NNP T) (JJ regulatory) (NN cell) (PRN (-LRB- -LRB-) (NNP Treg) (-RRB- -RRB-)) (NNS dynamics)) (PP (IN throughout) (NP (DT the) (NN lifetime))))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (NN model)) (PP (IN by) (NP (NNP Baltcheva))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (JJ initial) (NN simulation)) (VP (VBZ produces) (NP (NP (DT an) (NN inversion)) (PP (IN between) (NP (NN precursor) (CC and) (NN mature) (NNP Treys)))) (PP (IN at) (NP (NP (QP (IN around) (CD 20)) (NNS years)) (PP (IN of) (NP (NN age))))) (, ,) (SBAR (IN though) (S (NP (DT the) (NN output)) (VP (NNS differs) (ADVP (RB significantly)) (PP (IN from) (NP (DT the) (JJ original) (NN laboratory) (NN dataset)))))))))) (. .))
(S (ADVP (RB Secondly)) (, ,) (NP (DT this) (NN report)) (VP (VBZ discusses) (NP (NP (NN development)) (PP (IN of) (NP (DT the) (NN model))) (SBAR (S (VP (TO to) (VP (VB incorporate) (NP (NP (JJ new) (NNS data)) (PP (IN from) (NP (NP (DT a) (JJ cross-sectional) (NN study)) (PP (IN of) (NP (JJ healthy) (NN blood) (NNS donors))) (VP (VBG addressing) (NP (NP (NN balance)) (PP (IN between) (NP (NP (NNP Treys)) (CC and) (NP (NNP Th17) (NNS cells)))) (PP (IN with) (NP (NP (JJ novel) (NNS markers)) (PP (IN for) (NP (NNP Treg)))))))))))))))) (. .))
(S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NN simulation))) (VP (TO to) (VP (VB add) (NP (NP (JJ insight)) (PP (IN into) (NP (JJ immune) (NN aging))))))) (VP (VBZ is) (VP (VBN discussed))) (. .))
